Corcept Therapeutics | CORT - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Acadia Pharmaceuticals USD 26.32M 18.28M 2025-12
Alaunos Therapeutics USD -7.84M 633K 2023-12
ANI Pharmaceuticals USD 49.52M 39M 2025-09
Ardelyx USD -400K 467K 2025-12
Assertio Holdings USD -2.88M 648K 2024-09
Aurora Cannabis CAD -1.58M 48.55M 2025-12
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Canopy Growth CAD -62.26M 60.84M 2025-12
Corcept Therapeutics USD 15.24M 16.45M 2025-09
Eli Lilly USD 7.23B 456M 2025-09
Esperion Therapeutics USD 63.67M 95M 2025-12
J&J USD 4.97B 2.53B 2025-12
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Lexicon Pharmaceuticals USD -12.77M 16.02M 2025-09
Merck USD 6.74B 22M 2025-09
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Novartis USD 4.64B 445M 2025-12
Novartis USD 5.17B 637M 2025-09
Omeros USD -65.12M 21.27M 2024-06
Pacira USD 9.52M 11.45M 2025-09
Pfizer USD 3.33B 290M 2025-09
Supernus Pharmaceuticals USD -1.91M 56.04M 2025-12
TG Therapeutics USD 45.09M 19.18M 2025-12